实用肿瘤学杂志 ›› 2021, Vol. 35 ›› Issue (2): 117-124.doi: 10.11904/j.issn.1002-3070.2021.02.004

• 临床研究 • 上一篇    下一篇

中性粒细胞与淋巴细胞比值在非小细胞肺癌患者预后评估中的临床意义及相关机制研究

尹蕾1,2, 杨旭东1,2, 杨悦1,2, 牛星鉴3, 周晓平3, 姬宏飞1,2, 王一然1,2   

  1. 1.哈尔滨医科大学肿瘤防治研究所(哈尔滨 150081);
    2.黑龙江省医学科学院;
    3.哈尔滨医科大学附属肿瘤医院肿瘤内科
  • 收稿日期:2020-11-28 修回日期:2021-03-02 出版日期:2021-04-28 发布日期:2021-04-27
  • 通讯作者: 王一然,E-mail:yiranwang@hrbmu.edu.cn
  • 作者简介:尹蕾,女,(1992-),硕士,研究实习员,从事肿瘤学基础的研究。
  • 基金资助:
    国家自然科学基金(面上项目)(编号:82002781);黑龙江省自然科学基金(省留学归国人员科学基金)(编号:LC2017037)

The clinical significance and related mechanism of neutrophil to lymphocyte ratio in the prognostic evaluation of patients with non small cell lung cancer

YIN Lei1,2, YANG Xudong1,2, YANG Yue1,2, NIU Xingjian3, ZHOU Xiaoping3, JI Hongfei1,2, WANG Yiran1,2   

  1. 1. Institute of Cancer Prevention and Treatment,Harbin Medical University,Harbin 150081,China;
    2. Heilongjiang Academy of Medical Sciences;
    3. Department of Medical Oncology,Harbin Medical University Cancer Hospital
  • Received:2020-11-28 Revised:2021-03-02 Online:2021-04-28 Published:2021-04-27

摘要: 目的 探讨非小细胞肺癌(Non-small cell lung cancer,NSCLC)患者治疗前中性粒细胞/淋巴细胞比值(Neutrophils to lymphocytes ratio,NLR)与预后关系,阐释相关机制。方法 收集2007年1月—2009年12月在哈尔滨医科大学附属肿瘤医院接受放射治疗的302例NSCLC患者做建模组,2010年1月—2010年6月的96例患者做验证组。建模组内绘制ROC曲线评价NLR对患者复发的预测价值;分析治疗前NLR与患者临床指征及预后关系;分析患者预后影响因素。建立列线图模型,验证组进行验证。免疫组织化学法检测肿瘤组织中血清淀粉样蛋白酶A(Serum amyloid A,SAA)和中性粒细胞表达;ELISA检测患者血清中SAA浓度;RT-PCR和免疫蛋白印迹法检测NSCLC细胞中SAA表达;流式细胞术分析SAA对中性粒细胞凋亡影响,并检测凋亡相关蛋白表达。结果 建模组ROC曲线显示,治疗前NLR对NSCLC患者复发有一定的诊断价值(AUC=0.679,P=0.013),NLR最佳分界值为2.53;按高、低NLR分组,发现NLR与ECOG评分、病理分期和肿瘤分级有关;低NLR组患者总生存期和无病生存期更长(P<0.01)。总生存期列线图模型对建模组患者3、5年生存率预测的AUC值分别为0.723和0.625,对验证组3、5年生存率预测的AUC值分别为0.749和0.705。NLR高的患者肿瘤组织中中性粒细胞浸润度高,SAA高表达(P<0.01);患者血清中SAA浓度显著升高(P<0.01),SAA浓度与中性粒细胞数量呈正相关(P<0.01);NSCLC细胞中SAA mRNA和蛋白表达显著升高(P<0.01);流式结果显示,SAA有效抑制中性粒细胞凋亡;中性粒细胞经SAA处理后Caspase-3表达降低,Bcl-2表达升高(P<0.05)。结论 治疗前NLR水平可作为NSCLC患者预后风险评价指标;SAA抑制中性粒细胞凋亡,影响NLR水平。

关键词: 非小细胞肺癌, 中性粒细胞与淋巴细胞数比值, 血清淀粉样蛋白A, 预后, 凋亡

Abstract: Objective The aims of this study were to investigate the relationship between the pre-treatment neutrophils to lymphocytes ratio(NLR)and prognosis of patients with non small cell lung cancer(NSCLC),and to explain the relevant mechanism. Methods A total of 302 NSCLC patients who received radiotherapy in Harbin Medical University Cancer Hospital from January 2007 to December 2009 were collected as the modeling group,and 96 patients from January 2010 to June 2010 were collected as the validation group.The ROC curve in the modeling group was used to evaluate the predictive value of NLR for patient recurrence;the relationship between NLR and clinical indications and prognosis before treatment,and the factors affecting the prognosis of patients were analyzed.A nomogram model was established and verified in the validation group.Immunohistochemistry was used to detect serum amyloid A(SAA)and neutrophil expression in tumor tissues;ELISA was used to detect the plasma concentration of SAA in patients;RT-PCR and Western blotting were used to detect the expression of SAA in NSCLC cells;Flow cytometry was used to analyze the effect of SAA on neutrophil apoptosis and detect the expression of apoptosis protein. Results The ROC curve in the modeling group showed that NLR had a certain diagnostic value for the recurrence of NSCLC patients before treatment(AUC=0.679,P=0.013),and the best cutoff of NLR was 2.53;Grouped by high and low NLR,NLR was correlated withand ECOG,pathological stage and tumor grade;Patients in the low NLR group have longer overall survival and disease-free survival(P<0.01).The AUC values of the overall survival nomogram model for the prediction of the 3 and 5 year survival rates in the modeling group were 0.723 and 0.625,respectively,and the AUC values for the prediction of the 3 and 5 year survival rates in the validation group were 0.749 and 0.705,respectively.Patients with high NLR had a high neutrophil infiltration and high expression of SAA in tumor tissues(P<0.01);The concentration of SAA in patients' serum was significantly increased(P<0.01),and SAA concentration was positively correlated with the number of neutrophils(P<0.01);expression of SAA mRNA and protein in NSCLC cells were significantly increased(P<0.01);Flow cytometry results showed that SAA effectively inhibited neutrophil apoptosis;After neutrophils treated with SAA,the expression of Caspase-3 decreased,and Bcl-2 expression increased(P<0.05). Conclusion The level of NLR before treatment can be used as an indicator of prognostic risk for NSCLC patients;SAA inhibits neutrophil apoptosis and affects the level of NLR.

Key words: Non-small cell lung cancer;Neutrophils to lymphocytes ratio;Serum amyloid A;Prognosis;Apoptosis

中图分类号: